✦ 24h Briefing Top Stories World U.S.India Business Technology Science Health Sports Entertainment

Loading

Fetching the latest headlines…

NabkaNews aggregates headlines from thousands of publishers worldwide via Google News, and provides AI-generated summaries and briefings for convenience. Every story links to its original source. We do not host or claim ownership of third-party reporting, and AI summaries may contain errors — always verify with the original source.

24h Briefing Top Stories World U.S.India Business Technology Science Health Sports Entertainment

Disclaimer Privacy Policy Terms of Use

© 2026 NabkaNews · World · U.S. · India — updated continuously. NabkaNews is an independent news aggregator and is not affiliated with any publisher shown.

Intraperitoneal programming of tailored CAR macrophages via mRNA lipid nanoparticle to boost cancer immunotherapy · NabkaNews

← Back to headlines

Intraperitoneal programming of tailored CAR macrophages via mRNA lipid nanoparticle to boost cancer immunotherapy

Nature·Dec 24

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Researchers are exploring a method to enhance cancer immunotherapy by programming tailored CAR macrophages. This approach involves using mRNA lipid nanoparticles to deliver the programming intraperitoneally. The goal of this method is to boost the effectiveness of cancer immunotherapy.

Full coverage

CAR-M therapy in the era of tumor immunotherapy: current research progress and engineering strategies

Frontiers·Jan 13

Immune cell engineering for cancer therapy 2026

Lung metastasis and recurrence is mitigated by CAR macrophages, in-situ-generated from mRNA delivered by small extracellular vesicles

Targeting inflammation with chimeric antigen receptor macrophages using a signal switch

Advances and prospects in cell therapy for cancer: explorations from T cells to stem cells

Cancer immunotherapy

Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers

View original report at Nature ↗